Table #: Antibody plaque-forming cell (PFC) assay
|
Test Group (n = #) |
Spleen Cells (x 107) |
Specific Activity (IgM AFC/106 spleen cells) |
Total Spleen Activity (IgM AFC/spleen (x 103)) |
|
Male | |||
|
Control |
|
|
|
|
Dose 1 |
|
|
|
|
Dose 2 |
|
|
|
|
Dose 3 |
|
|
|
|
Positive Control (name of substance) |
|
|
|
|
Female | |||
|
Control |
|
|
|
|
Dose 1 |
|
|
|
|
Dose 2 |
|
|
|
|
Dose 3 |
|
|
|
|
Positive Control (name of substance) |
|
|
|
* Significantly different (p <0.05) from the control.
** Significantly different (p <0.01) from the control.